MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Evofem Biosciences, Inc. (EVFM)

Evofem Biosciences, Inc. (EVFM)

|||

Balance Sheets Overview

Current Ratio
6.86%
Quick Ratio
4.43%
Debt to Asset Ratio
1196.65%
Unit: Thousand (K) dollars
Assets Breakdown
    • Trade accounts receivable, net
    • Restricted cash and cash equival...
    • Less accumulated depreciation
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Convertible notes-Adjuvant Notes
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
-
1,491
578
-
Restricted cash
-
-
-
840
Restricted cash and cash equivalents
285
888
-
-
Trade accounts receivable, net
2,497
560
12,480
4,435
Inventories
2,155
1,890
1,129
1,684
Prepaid and other current assets
1,145
1,227
1,097
959
Total current assets
6,082
6,056
15,284
7,918
Property and equipment, gross
535
535
534
532
Less accumulated depreciation
123
119
116
112
Property and equipment, net
412
416
418
420
Operating lease right-of-use assets
118
150
182
195
Intangible asset, net (note 7)
869
778
4,348
5,238
Other noncurrent assets
41
42
42
36
Total assets
7,522
7,442
20,274
13,807
Accounts payable
12,150
12,003
13,153
11,624
Convertible notes-Baker Bros Notes
18,616
18,080
20,097
18,509
Convertible notes-Related Party
1,219
843
1,352
983
Convertible notes-Adjuvant Notes
34,010
33,384
32,770
32,167
Short-term debt
362
-
147
291
Accrued expenses
1,571
1,205
1,292
1,363
Accrued compensation
2,177
1,495
2,587
3,609
Operating lease liabilities current
114
123
128
124
Derivative liabilities
6,913
1,168
1,006
1,140
Contingent liabilities - current (note 7)
312
220
272
215
Other current liabilities
11,171
10,231
12,016
8,161
Total current liabilities
88,615
78,752
84,820
78,186
Operating lease liabilities noncurrent
4
27
54
72
Contingent liabilities - noncurrent (note 7)
1,393
1,375
4,837
5,718
Total liabilities
90,012
80,154
89,711
83,976
Convertible and redeemable preferred stock
5,026
4,918
4,899
4,897
Common stock, 0.0001 par value 3,000,000,000 shares authorized 132,530,081 and 126,685,925 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
13
13
13
12
Additional paid-in capital
831,875
831,875
831,859
831,816
Accumulated other comprehensive loss
-5,385
-6,643
-8,818
-6,718
Accumulated deficit
-914,019
-902,875
-897,390
-900,176
Total stockholders deficit
-87,516
-77,630
-74,336
-75,066
Total liabilities, convertible and redeemable preferred stock and stockholders deficit
7,522
7,442
20,274
13,807
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Trade accountsreceivable, net$2,497K (-49.39%↓ Y/Y)Inventories$2,155K (13.06%↑ Y/Y)Prepaid and othercurrent assets$1,145K (-17.15%↓ Y/Y)Restricted cash and cashequivalents$285K Property and equipment,gross$535K (0.56%↑ Y/Y)Total current assets$6,082K (-32.20%↓ Y/Y)Intangible asset, net (note7)$869K (-81.66%↓ Y/Y)Property and equipment,net$412K (-2.83%↓ Y/Y)Operating leaseright-of-use assets$118K (-44.86%↓ Y/Y)Other noncurrentassets$41K (13.89%↑ Y/Y)Less accumulateddepreciation$123K (13.89%↑ Y/Y)Total assets$7,522K (-47.70%↓ Y/Y)Accumulated deficit-$914,019K (-1.73%↓ Y/Y)Accumulated othercomprehensive loss-$5,385K (-110.68%↓ Y/Y)Total liabilities,convertible and redeemable...$7,522K (-47.70%↓ Y/Y)Total stockholdersdeficit-$87,516K (-25.71%↓ Y/Y)Additional paid-in capital$831,875K (0.05%↑ Y/Y)Common stock, 0.0001par value...$13K (8.33%↑ Y/Y)Total liabilities$90,012K (13.63%↑ Y/Y)Convertible and redeemablepreferred stock$5,026K (5.01%↑ Y/Y)Total currentliabilities$88,615K (19.92%↑ Y/Y)Contingent liabilities -noncurrent (note 7)$1,393K (-73.37%↓ Y/Y)Operating leaseliabilities noncurrent$4K (-95.51%↓ Y/Y)Convertible notes-AdjuvantNotes$34,010K (6.50%↑ Y/Y)Convertible notes-BakerBros Notes$18,616K (26.24%↑ Y/Y)Accounts payable$12,150K (-1.15%↓ Y/Y)Other currentliabilities$11,171K (47.20%↑ Y/Y)Derivative liabilities$6,913K (230333.33%↑ Y/Y)Accrued compensation$2,177K (-32.99%↓ Y/Y)Accrued expenses$1,571K (-52.78%↓ Y/Y)Convertible notes-RelatedParty$1,219K (3382.86%↑ Y/Y)Short-term debt$362K (-5.48%↓ Y/Y)Contingent liabilities -current (note 7)$312K (46.48%↑ Y/Y)Operating leaseliabilities current$114K (-8.06%↓ Y/Y)